Literature DB >> 24260591

A practical guide to treatment of infantile hemangiomas of the head and neck.

Jia Wei Zheng1, Ling Zhang, Qin Zhou, Hua Ming Mai, Yan An Wang, Xin Dong Fan, Zhong Ping Qin, Xv Kai Wang, Yi Fang Zhao.   

Abstract

Infantile hemangiomas are the most common benign vascular tumors in infancy and childhood. As hemangioma could regress spontaneously, it generally does not require treatment unless proliferation interferes with normal function or gives rise to risk of serious disfigurement and complications unlikely to resolve without treatment. Various methods for treating infant hemangiomas have been documented, including wait and see policy, laser therapy, drug therapy, sclerotherapy, radiotherapy, surgery and so on, but none of these therapies can be used for all hemangiomas. To obtain the best treatment outcomes, the treatment protocol should be individualized and comprehensive as well as sequential. Based on published literature and clinical experiences, we established a treatment guideline in order to provide criteria for the management of head and neck hemangiomas. This protocol will be renewed and updated to include and reflect any cutting-edge medical knowledge, and provide the newest treatment modalities which will benefit our patients.

Entities:  

Keywords:  Hemangiomas; drug therapy; head and neck; sclerotherapy; treatment

Year:  2013        PMID: 24260591      PMCID: PMC3832322     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  41 in total

1.  Radiotherapy of childhood haemangiomas: from active treatment to radiation risk estimates.

Authors:  S Lindberg
Journal:  Radiat Environ Biophys       Date:  2001-09       Impact factor: 1.925

2.  Cellular and extracellular markers of hemangioma.

Authors:  S T Tan; M Velickovic; B M Ruger; P F Davis
Journal:  Plast Reconstr Surg       Date:  2000-09       Impact factor: 4.730

Review 3.  Lasers in dermatology: four decades of progress.

Authors:  Elizabeth L Tanzi; Jason R Lupton; Tina S Alster
Journal:  J Am Acad Dermatol       Date:  2003-07       Impact factor: 11.527

4.  Birthmarks in infants.

Authors:  A G PRATT
Journal:  AMA Arch Derm Syphilol       Date:  1953-03

5.  Guidelines of care for hemangiomas of infancy. American Academy of Dermatology Guidelines/Outcomes Committee.

Authors:  I J Frieden; L F Eichenfield; N B Esterly; R Geronemus; S B Mallory
Journal:  J Am Acad Dermatol       Date:  1997-10       Impact factor: 11.527

6.  Treatment of capillary hemangiomas of early childhood with a new method of cryosurgery.

Authors:  S Reischle; S Schuller-Petrovic
Journal:  J Am Acad Dermatol       Date:  2000-05       Impact factor: 11.527

7.  Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.

Authors:  Nhung T C Ho; Perla Lansang; Elena Pope
Journal:  J Am Acad Dermatol       Date:  2007-01       Impact factor: 11.527

8.  Adverse effects associated with the 577- and 585-nanometer pulsed dye laser in the treatment of cutaneous vascular lesions: a study of 500 patients.

Authors:  V J Levine; R G Geronemus
Journal:  J Am Acad Dermatol       Date:  1995-04       Impact factor: 11.527

9.  Congenital vascular lesions: clinical application of a new classification.

Authors:  M C Finn; J Glowacki; J B Mulliken
Journal:  J Pediatr Surg       Date:  1983-12       Impact factor: 2.545

Review 10.  Management of congenital vascular lesions of the head and neck.

Authors:  M Waner; J Y Suen
Journal:  Oncology (Williston Park)       Date:  1995-10       Impact factor: 2.990

View more
  22 in total

1.  A survey on clinical use of propranolol for infantile hemangiomas in mainland China.

Authors:  Zheng-Gang Chen; Jia-Wei Zheng; Ling Zhang; Ling Zhu; Yan-An Wang
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Management of periorbital hemangioma by intralesional glucocorticoids and systemic propranolol: a single-center retrospective study.

Authors:  Si-Ming Yuan; Lei Cui; Yao Guo; Chun-Yan Xue; Zhi-Jian Hong; Hui-Qing Jiang
Journal:  Int J Clin Exp Med       Date:  2014-04-15

3.  Target radiofrequency combined with collagenase chemonucleolysis in the treatment of lumbar intervertebral disc herniation.

Authors:  Daying Zhang; Yong Zhang; Zhijian Wang; Xuexue Zhang; Mulan Sheng
Journal:  Int J Clin Exp Med       Date:  2015-01-15

Review 4.  Mosaicism in Cutaneous Disorders.

Authors:  Young H Lim; Zoe Moscato; Keith A Choate
Journal:  Annu Rev Genet       Date:  2017-11-27       Impact factor: 16.830

5.  Rosiglitazone accentuates the adipogenesis of hemangioma-derived mesenchymal stem cells induced by adipogenic media.

Authors:  Si-Ming Yuan; Yao Guo; Xiao-Jun Zhou; Wei-Min Shen; Hai-Ni Chen
Journal:  Int J Clin Exp Med       Date:  2014-07-15

6.  A hydrogel-endothelial cell implant mimics infantile hemangioma: modulation by survivin and the Hippo pathway.

Authors:  Masayuki Tsuneki; Steven Hardee; Michael Michaud; Raffaella Morotti; Erin Lavik; Joseph A Madri
Journal:  Lab Invest       Date:  2015-05-11       Impact factor: 5.662

7.  PDGFR-β (+) perivascular cells from infantile hemangioma display the features of mesenchymal stem cells and show stronger adipogenic potential in vitro and in vivo.

Authors:  Si-Ming Yuan; Yao Guo; Xiao-Jun Zhou; Wei-Min Shen; Hai-Ni Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-05-15

8.  Intralesional Bevacizumab (Avastin®) as a Novel Addition to Infantile Hemangioma Management: A Medical Hypothesis.

Authors:  Mohsen Pourazizi; Sattar Kabiri; Bahareh Abtahi-Naeini
Journal:  J Res Pharm Pract       Date:  2017 Jul-Sep

9.  Case report: chronic inflammatory ulcer and osteoradionecrosis of the skull following radiotherapy in early childhood.

Authors:  Birte Julia Siegmund; Jan Rustemeyer
Journal:  Oral Maxillofac Surg       Date:  2019-04-23

10.  Effect of combined low-dose oral prednisone with beta-adrenergic receptor antagonists for refractory infantile hemangiomas: retrospective cohort study in 76 patients.

Authors:  Chao Liu; Ze-Liang Zhao; Hai-Wei Wu; Jia-Wei Zheng; Yan-An Wang; Xue-Jian Liu; Xin-Dong Fan
Journal:  Ann Transl Med       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.